Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05244733 · ClinicalTrials.gov registry record · NA
Culture and Well-Being for Latinos
A NA study of Suicidal Ideation and Loneliness, sponsored by University of Rochester.
- Completed
- Registry status
- NA
- Development phase
- 54
- Enrollment target
- 1
- Study location
NCT05244733: Completed NA study of Suicidal Ideation and Loneliness, sponsored by University of Rochester.
NCT05244733 is a NA study of Suicidal Ideation and Loneliness that has completed, run by University of Rochester. The registered enrollment target is 54 participants, below the 267-participant average among 84 other Suicidal Ideation trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05244733, a NA study of Suicidal Ideation and Loneliness, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- NA
- Development phase
- 54 participants
- Enrollment target
- 1
- Study location
Study Summary
The proposed K23 study is an intervention study using an experimental therapeutics approach. This pilot RCT asks: "Does SOCIAL-ENGAGE increase cultural-social engagement and decrease suicide risk among Spanish-speaking adults?" We will first optimize a behavioral intervention - SOCIAL ENGAGE (S-ENGAGE) - for target engagement using human-centered design approaches with Spanish-speaking adults at risk for suicide (n=5) and then conduct a pilot RCT (n=60) to test target engagement (cultural-social engagement) and clinical impact (suicide risk) of S-ENGAGE with this population. The ultimate goal is for S-ENGAGE to be offered as a suicide prevention program for Hispanics at risk for suicide.
Primary Outcome
Average number of cultural-social interactions (measured via EMA), with greater number indicating greater cultural-social engagement (i.e., better outcome).
Conditions Studied
Interventions
- BEHAVIORAL Social Engage (S-ENGAGE)
- BEHAVIORAL The Healthy Lifestyles Education Program
Study Locations (1)
New York
- University of Rochester Medical Center - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2022-06-01 |
| Est. Completion | 2025-09-19 |
| Phase | NA |
What the finished NCT05244733 record still lists
NCT05244733 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 54 participants, a relatively small participant target, below the 267-participant average among 84 other Suicidal Ideation trials with a reported enrollment target (80% lower).
The record links to 3 conditions, with Suicidal Ideation appearing as the primary indexed condition, and to 2 interventions - of which Social Engage (S-ENGAGE) is the first listed.
NCT05244733 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT05244733 about?
NCT05244733 is a clinical study titled "Culture and Well-Being for Latinos". The proposed K23 study is an intervention study using an experimental therapeutics approach. This pilot RCT asks: "Does SOCIAL-ENGAGE increase cultural-social engagement and decrease suicide risk among Spanish-speaking adults?" We will first optimize a behavioral intervention - SOCIAL ENGAGE (S-ENGA...
What is the current status of trial NCT05244733?
This trial is currently completed. It is a NA study. The enrollment target is 54 participants. The study started on 2022-06-01. Estimated completion is 2025-09-19.
What conditions does trial NCT05244733 study?
This clinical trial studies the following conditions: Suicidal Ideation, Loneliness, Social Isolation.
What interventions are being tested in trial NCT05244733?
The interventions under investigation include: Social Engage (S-ENGAGE) (BEHAVIORAL), The Healthy Lifestyles Education Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT05244733?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05244733 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Suicidal Ideation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05244733's enrollment target sits among peer trials
54 65th of 84 higher than 19 of 84 other Suicidal Ideation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Suicidal Ideation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Randomized Clinical Trial of Supplementing Brief Psychotherapy With a Mobile App
RECRUITING · NA
-
Efficacy, Effectiveness, and Implementation of Jaspr Health in Emergency Department- Part A
RECRUITING · NA
-
Inhibitory Mechanisms of Negative Urgency in Adolescent Suicidal Behavior
RECRUITING · NA
-
Augmenting Massed Cognitive Processing Therapy (CPT) to Prevent Suicide Risk Among Patients With PTSD
RECRUITING · NA
-
Crisis Response Planning for Military Personnel
RECRUITING · NA
-
Suicide Intervention for Alaska Native Youth
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01269853 · 54 participants · Phase 1
Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA
- NCT02390752 · 54 participants · Phase 1
Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...
- NCT02991248 · 54 participants · NA
Improve Dynamic Lateral Balance of Humans With SCI
- NCT02993900 · 54 participants · NA
Image-Guided Gynecologic Brachytherapy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI